Side-by-side comparison of AI visibility scores, market position, and capabilities
Santa Clara semiconductor equipment (NASDAQ: AMAT) ~$27.2B FY2024 revenue; world's largest semiconductor equipment company, HBM advanced packaging for AI GPUs, 50,000+ tools worldwide competing with ASML and Lam Research.
Applied Materials, Inc. is a Santa Clara, California-based semiconductor and display equipment company — publicly traded on NASDAQ (NASDAQ: AMAT) as an S&P 500 Information Technology component — providing manufacturing equipment, services, and software used to fabricate virtually every chip and advanced display in the world through approximately 35,000 employees serving foundries, integrated device manufacturers, and memory makers in 24 countries. Applied Materials is the world's largest semiconductor equipment company by revenue, supplying deposition (CVD, PVD, ALD), etch, ion implant, chemical mechanical planarization (CMP), metrology and inspection, and advanced packaging equipment to leading chipmakers including TSMC, Samsung, Intel, SK Hynix, and Micron. In fiscal year 2024 (ending October 2024), Applied Materials reported revenue of approximately $27.2 billion, with strong demand driven by leading-edge foundry investments at TSMC and Samsung for AI accelerator chips and advanced memory for HBM (high-bandwidth memory) stacks used in NVIDIA and AMD AI GPUs. The company's Semiconductor Systems segment commands the largest market share of any equipment category, while the Applied Global Services (AGS) segment generates recurring spare parts and service revenue from the installed base of 50,000+ tools operating worldwide. CEO Gary Dickerson has led Applied Materials' strategy of expanding beyond commodity deposition and etch into advanced packaging, gate-all-around transistor manufacturing, and materials engineering — where Applied's breadth of materials deposition capabilities creates competitive differentiation.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.